1. Academic Validation
  2. Simultaneous determination of TUG-891 and its metabolites in rat plasma using LC-HRMS with application to preclinical pharmacokinetic study

Simultaneous determination of TUG-891 and its metabolites in rat plasma using LC-HRMS with application to preclinical pharmacokinetic study

  • Biomed Chromatogr. 2020 Sep;34(9):e4870. doi: 10.1002/bmc.4870.
Jiping Yi 1 Bin Chen 2 Yongzheng Bao 3 Jingyu Wang 4
Affiliations

Affiliations

  • 1 Department of Neurology, Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan Province, China.
  • 2 Department of Spine Surgery, Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan Province, China.
  • 3 Department of Spine Surgery, Yuebei People's Hospital, Shantou University, Shaoguan, Guangdong Province, China.
  • 4 Department of Clinical Pharmacy, Translational Medicine Institute, The First People's Hospital of Chenzhou, University of South China, Chenzhou, Hunan Province, China.
Abstract

In this study, a simple and reliable LC-MS/MS method was first proposed for the simultaneous determination of TUG-891 and its metabolites TUG-891-alcohol, TUG-891-aldehyde, and TUG-891-acid in rat plasma. The analytes and fasiglifam (internal standard) were extracted from plasma samples with acetonitrile and separated using an Acquity BEH C18 column (1.7 μm, 2.1 × 50 mm) with water containing 0.05% ammonium hydroxide and acetonitrile containing 0.05% ammonium hydroxide as the mobile phase. A Q-Exactive Orbitrap mass spectrometer in full-scan mode was used for mass detection, and the data analysis was obtained using a mass extraction window of 5 ppm. The calibration curves exhibited excellent linearity (correlation coefficient > 0.9981) in the concentration range of 0.5-1000 ng/mL. The lower limit of quantification was 0.5 ng/mL for all analytes. The intra- and inter-day precision was less than 11.31%, and the accuracy ranged from -11.50 to 9.50%. The extraction recovery of the analytes from rat plasma was greater than 82.31%, and no obvious matrix effect was found. The established method was further applied to the pharmacokinetic study of TUG-891, TUG-891-alcohol, TUG-891-aldehyde, and TUG-891-acid in rat after a single dose of 5-mg/kg treatment of TUG-891. The results demonstrated that TUG-891 was rapidly metabolized into its metabolites and the systemic exposures of the metabolites were much higher than those of TUG-891.

Keywords

LC-MS/MS; TUG-891; oxidative metabolites; pharmacokinetics.

Figures
Products